Sonendo, Inc. is a medical technology company, which developed and manufactures the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 131 full-time employees. The company went IPO on 2021-10-29. The firm develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to dissolve tissue and bacteria using minimal or no instrumentation. Its Product segment includes the sales of the GentleWave System console and related accessories and instruments. The firm also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown.
How did SONX's recent EPS compare to expectations?
The most recent EPS for Sonendo Inc is $, expectations of $-16.32.
How did Sonendo Inc SONX's revenue perform in the last quarter?
Sonendo Inc revenue for the last quarter is $
What is the revenue estimate for Sonendo Inc?
According to of Wall street analyst, the revenue estimate of Sonendo Inc range from $ to $
What's the earning quality score for Sonendo Inc?
Sonendo Inc has a earning quality score of A-/61.998222. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Sonendo Inc report earnings?
Sonendo Inc next earnings report is expected in 2026-07-26
What are Sonendo Inc's expected earnings?
Sonendo Inc expected earnings is $9.99M, according to wall-street analysts.